RT @WrigleyTom: ER's
$JPM $BAC $WFC $BLK $KBH $DAL
---
#JPM17
$CELG $AMGN $VRX $JUNO
$BLUE $KITE $ONCE $CLVS
$GILD $REGN $SGEN $BIIB
$BMRN…
RT @WrigleyTom: ER's
$JPM $BAC $WFC $BLK $KBH $DAL
---
#JPM17
$CELG $AMGN $VRX $JUNO
$BLUE $KITE $ONCE $CLVS
$GILD $REGN $SGEN $BIIB
$BMRN…
RT @WrigleyTom: ER's
$JPM $BAC $WFC $BLK $KBH $DAL
---
#JPM17
$CELG $AMGN $VRX $JUNO
$BLUE $KITE $ONCE $CLVS
$GILD $REGN $SGEN $BIIB
$BMRN…
RT @JacobPlieth: $KITE takes on $JUNO & local players in China, & pushes into Japan, via @EPVantage #JPM17 https://t.co/fcN7DPH20U
RT @JacobPlieth: $KITE takes on $JUNO & local players in China, & pushes into Japan, via @EPVantage #JPM17 https://t.co/fcN7DPH20U
RT @JacobPlieth: $KITE takes on $JUNO & local players in China, & pushes into Japan, via @EPVantage #JPM17 https://t.co/fcN7DPH20U
$KOOL is tomorrow's low float ticker! Got FDA approval recently. This piggy can fly with volume. PT: $6. Get in. $KITE $HTZ $MYL $XON $AG
$KITE takes on $JUNO & local players in China, & pushes into Japan, via @EPVantage #JPM17 https://t.co/fcN7DPH20U
$KITE Kite Pharma and Fosun Pharma Establish Joint Venture in China to Develop and Commercialize Autologou... - https://t.co/13l0FMCX0W
$KOOL is tomorrow's low float ticker! Got FDA approval recently. This piggy can fly with volume. PT: $6. Get in. $KITE $JUNO $REN $REXX
$KITE:
Kite Pharma and Fosun Pharma Establish Joint Venture in China to …:
https://t.co/gisoo2fVvM
$KITE - Kite Pharma & Fosun Pharma Establish Joint Venture in China to Develop & Commercialize Autologous https://t.co/xlrw7cfoxW
RT @theflynews: On The Fly: After Hours Movers $CUDA $VOXX $KITE $WDFC $BOOT $WMB $WPZ $FRSH $ATW $HALO $CIO $NBR $SCVL $ZLTQ $CRAY https:/…
RT @theflynews: On The Fly: After Hours Movers $CUDA $VOXX $KITE $WDFC $BOOT $WMB $WPZ $FRSH $ATW $HALO $CIO $NBR $SCVL $ZLTQ $CRAY https:/…
RT @JacobPlieth: $KITE Japan deal is interesting. Relatively little CAR-T activity in Japan besides Takara Bio & 2 hospitals running $NVS J…
RT @theflynews: On The Fly: After Hours Movers $CUDA $VOXX $KITE $WDFC $BOOT $WMB $WPZ $FRSH $ATW $HALO $CIO $NBR $SCVL $ZLTQ $CRAY https:/…
RT @endpts: Daiichi Sankyo grabs licensing rights to Kite’s pioneering CAR-T drug in $250M+ deal https://t.co/ixKcv8I1EZ… $KITE #immunoOnco…
RT @JacobPlieth: $KITE Japan deal is interesting. Relatively little CAR-T activity in Japan besides Takara Bio & 2 hospitals running $NVS J…
RT @JohnCendpts: Daiichi Sankyo grabs licensing rights to Kite’s pioneering CAR-T drug in $250M-plus deal
$KITE
https://t.co/HhDN1H62z8
RT @endpts: Daiichi Sankyo grabs licensing rights to Kite’s pioneering CAR-T drug in $250M+ deal https://t.co/ixKcv8I1EZ… $KITE #immunoOnco…
Daiichi Sankyo grabs licensing rights to Kite’s pioneering CAR-T drug in $250M+ deal https://t.co/ixKcv8I1EZ… $KITE #immunoOncology #biotech
https://t.co/GhgsY9wZc4 <- Want to make $600,00 In One Year Trading? Check out how this guy did it! $BBRY $UWTI $KITE
RT @theflynews: On The Fly: After Hours Movers $CUDA $VOXX $KITE $WDFC $BOOT $WMB $WPZ $FRSH $ATW $HALO $CIO $NBR $SCVL $ZLTQ $CRAY https:/…
RT @theflynews: On The Fly: After Hours Movers $CUDA $VOXX $KITE $WDFC $BOOT $WMB $WPZ $FRSH $ATW $HALO $CIO $NBR $SCVL $ZLTQ $CRAY https:/…
RT @theflynews: On The Fly: After Hours Movers $CUDA $VOXX $KITE $WDFC $BOOT $WMB $WPZ $FRSH $ATW $HALO $CIO $NBR $SCVL $ZLTQ $CRAY https:/…
RT @JessicaCerka: KTE-C19 to encounter tough negotiations with payers reported by @AlaricJDeArment @BioPharmInsight $KITE #JPM17 #bpinews
RT @theflynews: On The Fly: After Hours Movers $CUDA $VOXX $KITE $WDFC $BOOT $WMB $WPZ $FRSH $ATW $HALO $CIO $NBR $SCVL $ZLTQ $CRAY https:/…
RT @JacobPlieth: $KITE Japan deal is interesting. Relatively little CAR-T activity in Japan besides Takara Bio & 2 hospitals running $NVS J…
$BLUE $OBMP $INCY $MDCO $KITE Biotech : 5 Buyout Candidates To Keep An Eye On in 2017 https://t.co/9kXQYXNeWg …
$BLUE $OBMP $INCY $MDCO $KITE Biotech : 5 Buyout Candidates To Keep An Eye On in 2017 https://t.co/DD7rBNnhFS …
RT @JohnCendpts: Daiichi Sankyo grabs licensing rights to Kite’s pioneering CAR-T drug in $250M-plus deal
$KITE
https://t.co/HhDN1H62z8
$BLUE $OBMP $INCY $MDCO $KITE Biotech : 5 Buyout Candidates To Keep An Eye On in 2017 https://t.co/DZF5KQLQcN …
$BLUE $OBMP $INCY $MDCO $KITE Biotech : 5 Buyout Candidates To Keep An Eye On in 2017 https://t.co/4y2FbYhkNy …
RT @theflynews: On The Fly: After Hours Movers $CUDA $VOXX $KITE $WDFC $BOOT $WMB $WPZ $FRSH $ATW $HALO $CIO $NBR $SCVL $ZLTQ $CRAY https:/…
$KITE Wants to fly higher https://t.co/MFbOHvcbRA
RT @TravisHoward5: Current Stocks on watch for 1/10/0 7 $NVDA $BABA $NFLX $TSLA $FB $GILD $FEYE $WDAY $KITE $JUNO $GWPH $GOOGL $AAPL - http…
Why KITE Is UP In After Hours Trading Kite Pharma https://t.co/EXCUMHCzej $KITE
Current Stocks on watch for 1/10/0 7 $NVDA $BABA $NFLX $TSLA $FB $GILD $FEYE $WDAY $KITE $JUNO $GWPH $GOOGL $AAPL - https://t.co/QNvxWLJkZ6
RT @pharmamaven: $CELG partner $JUNO in desperate shape-need to take $FATE over ASAP.They & $KITE ahead chronologically but $ZIOP will leap…
@MaverickNY that's why it has the nick name taxi cab -- ah em, I mean axi-cel. HT @AlaricJDeArment $kite
RT @endpts: Daiichi Sankyo grabs licensing rights to Kite’s pioneering CAR-T drug in $250M+ deal https://t.co/lfhQXk1FaT $KITE #immunoOncol…
https://t.co/DkEVfcc3Yj <- This 24 Year Old Is Up $600,00 In One Year Since Joining SuperTrades! $BLUE $KITE #stocks
RT @247WolfSt: $BLUE $OBMP $INCY $MDCO $KITE Biotech : 5 Buyout Candidates To Keep An Eye On in 2017 https://t.co/DHZAVhXJmy
RT @247WolfSt: $BLUE $OBMP $INCY $MDCO $KITE Biotech : 5 Buyout Candidates To Keep An Eye On in 2017 https://t.co/DHZAVhXJmy
RT @247WolfSt: $BLUE $OBMP $INCY $MDCO $KITE Biotech : 5 Buyout Candidates To Keep An Eye On in 2017 https://t.co/DHZAVhXJmy
RT @247WolfSt: $BLUE $OBMP $INCY $MDCO $KITE Biotech : 5 Buyout Candidates To Keep An Eye On in 2017 https://t.co/DHZAVhXJmy
RT @247WolfSt: $BLUE $OBMP $INCY $MDCO $KITE Biotech : 5 Buyout Candidates To Keep An Eye On in 2017 https://t.co/DHZAVhXJmy
$BLUE $OBMP $INCY $MDCO $KITE Biotech : 5 Buyout Candidates To Keep An Eye On in 2017 https://t.co/DHZAVhXJmy
@1MinuteStock compare that to $ADAP #Book Value is $2.78 --> why isn't it or $KITE trading at $14?
RT @JacobPlieth: .@adar170 But note the relatively recent accelerated pathway legislation for cell therapies in Japan $KITE https://t.co/ME…
RT @JacobPlieth: .@adar170 But note the relatively recent accelerated pathway legislation for cell therapies in Japan $KITE https://t.co/ME…
RT @JacobPlieth: $KITE Japan deal is interesting. Relatively little CAR-T activity in Japan besides Takara Bio & 2 hospitals running $NVS J…
Do you know that #Book Value for $KITE is $9.93 https://t.co/1PDhERRexQ
RT @JacobPlieth: $KITE takes on $JUNO & local players in China, & pushes into Japan, via @EPVantage #JPM17 https://t.co/fcN7DPH20U
Bullish or bearish for $KITE? Seasonality says... https://t.co/1Q2jdES5tW https://t.co/7W7GBNQa61
Life in the Fast Lane – Cellular Immunotherapy Monthly Review
$KITE $JUNO $BLUE $ADAP $BLCM $ZIOP $NVS $SGMO https://t.co/2eqDr4AgIe
After Hours Movers UP $CUDA $VOXX $KITE DOWN $WDFC $BOOT $WMB $WPZ $FRSH $ATW $HALO $CIO $NBR $SCVL $ZLTQ $CRAY
Kite Pharma to receive $40m upfront payment as it establishes #China JV with Fosun. https://t.co/AfFw17o8Xj
$KITE… https://t.co/4xmXYU2Li1